NCT02970539 Ph1b Study of Oraxol in Comb. w. Ramucirumab in Patients w. Gastric, Gastro-esophageal, or Esophageal Cancers Status UNKNOWN Phase PHASE1
NCT02960594 hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse Status COMPLETED Phase PHASE1
NCT02955173 Significance of Circulating Tumor Cells in the Treatment of Gastric and Rectal Cancer Status COMPLETED Phase NA
NCT02954536 Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer Status COMPLETED Phase PHASE2
NCT02949258 Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric Cancer Status UNKNOWN Phase PHASE2
NCT02946671 Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients Status COMPLETED Phase PHASE1
NCT02942329 Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT02931890 Multicentric Randomised Trial for Resectable Gastric Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02908451 A Study of AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary Cancer Status TERMINATED Phase PHASE1
NCT02903914 Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT02903498 The Maintenance Treatment of UFT in Advanced Gastric Cancer Status COMPLETED Phase PHASE2
NCT02901301 Pembrolizumab, Trastuzumab, HER2 Positive Gastric Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT02892643 Comparison of Laparoscopic Proximal Gastrectomy and Laparoscopic Total Gastrectomy Status COMPLETED Phase NA
NCT02872116 Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer Status COMPLETED Phase PHASE3